RAB9AP3
associated omics dataQ-omics provides the consensus-scored RAB9AP3 profile across patient tissues and cancer cell-line models. RAB9AP3 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in SKCM.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for RAB9AP3 — synthetic lethality, tumor antigen, and pembrolizumab response.
View premium →Survival associations
This table summarizes RAB9AP3 survival associations across molecular data types. RAB9AP3 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible RAB9AP3 RNA expression–survival associations across cancer types. High RAB9AP3 expression shows unfavorable associations in SKCM. The SKCM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify SKCM as the clearest survival context for RAB9AP3 RNA expression.
